270 related articles for article (PubMed ID: 15507866)
1. Atherosclerosis: immunopathogenesis and immunotherapy.
Ohashi R; Mu H; Yao Q; Chen C
Med Sci Monit; 2004 Nov; 10(11):RA255-60. PubMed ID: 15507866
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
3. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity to heat shock proteins in atherosclerosis.
Mandal K; Jahangiri M; Xu Q
Autoimmun Rev; 2004 Feb; 3(2):31-7. PubMed ID: 15003185
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. Predictive and protective autoimmunity in cardiovascular diseases: is vaccination therapy a reality?
Toubi E; Shoenfeld Y
Lupus; 2005; 14(9):665-9. PubMed ID: 16218463
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
George J
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis as an autoimmune condition.
Kleindienst R; Schett G; Amberger A; Seitz CS; Michaelis D; Metzler B; Dietrich H; Xu Q; Wick G
Isr J Med Sci; 1995 Oct; 31(10):596-9. PubMed ID: 7591681
[TBL] [Abstract][Full Text] [Related]
9. [Chronic inflammation, autoimmunity and atherosclerosis].
Zhu JJ; Wang X
Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):327-31. PubMed ID: 12650069
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
Nilsson J; Wigren M; Shah PK
Trends Cardiovasc Med; 2009 Nov; 19(8):272-6. PubMed ID: 20447570
[TBL] [Abstract][Full Text] [Related]
11. [Immunity, inflammation and atherosclerosis].
Capron L
Rev Neurol (Paris); 1993; 149(12):751-4. PubMed ID: 7997733
[TBL] [Abstract][Full Text] [Related]
12. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity in atherosclerosis.
Hansson GK
Curr Opin Lipidol; 1997 Oct; 8(5):301-11. PubMed ID: 9335954
[TBL] [Abstract][Full Text] [Related]
14. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis--an autoimmune disease.
Wick G; Xu Q
Exp Gerontol; 1999 Jul; 34(4):559-66. PubMed ID: 10817811
[TBL] [Abstract][Full Text] [Related]
16. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
17. Immunopathogenesis of atherosclerosis.
Ludewig B; Krebs P; Scandella E
J Leukoc Biol; 2004 Aug; 76(2):300-6. PubMed ID: 15039468
[TBL] [Abstract][Full Text] [Related]
18. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target.
Liu Y; Yu H; Zhang Y; Zhao Y
Med Hypotheses; 2008; 70(2):314-6. PubMed ID: 17689203
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for atherosclerosis: an emerging paradigm.
Shah PK; Chyu KY; Nilsson J
Rev Cardiovasc Med; 2004; 5(4):194-203. PubMed ID: 15580158
[TBL] [Abstract][Full Text] [Related]
20. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
Nilsson J; Fredrikson GN; Björkbacka H; Chyu KY; Shah PK
J Intern Med; 2009 Sep; 266(3):221-31. PubMed ID: 19702790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
